High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma.
about
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancerHypothalamic Obesity in Craniopharyngioma Patients: Disturbed Energy Homeostasis Related to Extent of Hypothalamic Damage and Its Implication for Obesity InterventionNeuroendocrine Disorders in Pediatric Craniopharyngioma PatientsBenefit of 1.5-T intraoperative MR imaging in the surgical treatment of craniopharyngiomas.Quality of life in patients with skull base tumors: current status and future challenges.Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma.Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program.Postoperative cerebral glucose metabolism in pediatric patients receiving proton therapy for craniopharyngioma.Craniopharyngioma: a pathologic, clinical, and surgical review.Childhood craniopharyngioma.Surgery for craniopharyngioma.Mortality and morbidity in adult craniopharyngioma.Childhood craniopharyngioma: 20-year institutional experience in Western Australia.Childhood craniopharyngioma: treatment strategies and outcomes.Management of craniopharyngiomas.The ophthalmic natural history of paediatric craniopharyngioma: a long-term review.The chronic syndromes after previous treatment of pituitary tumours.Risk-adapted, long-term management in childhood-onset craniopharyngioma.Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma.New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma.In vitro evaluation of ferrule effect and depth of post insertion on fracture resistance of fiber posts.Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomesEvaluation of a comprehensive care clinic model for children with brain tumor and risk for hypothalamic obesity.Long-term outcomes for adult craniopharyngioma following radiation therapy.A randomized, placebo-controlled trial of beloranib for the treatment of hypothalamic injury-associated obesity.Is there a role for targeted medical therapies in patients with craniopharyngiomas?Quality-of-life, mood and executive functioning after childhood craniopharyngioma treated with surgery and proton beam therapy.Quality of life and psychological outcome in patients treated for craniopharyngioma.Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007.Microstructural white matter alterations and hippocampal volumes are associated with cognitive deficits in craniopharyngioma.Craniopharyngioma in adultsImpact of neutrophil-lymphocyte ratio on long-term outcome in patients with craniopharyngiomaExercise training improves vascular function and secondary health measures in survivors of pediatric oncology related cerebral insult
P2860
Q24197545-1987F304-A1BA-4216-BC48-41018B6DDA4CQ26786921-17F5D157-25E7-49F8-BD4B-5F51C262D8C8Q26799613-3C82BDB8-B4B9-4F41-B16A-EF58A811CE48Q30318426-3FDAE093-BB50-4A81-AA5B-34A854CD0359Q30480837-1FF2989D-BDDA-422C-BB09-A45EE3354185Q34507975-98CE5CF1-C78B-47A4-B461-AD4A65672BAAQ36127457-E4648757-003F-4159-81ED-8B80D9A257E1Q37433334-2E55EF28-6CBE-4CFE-8650-84BCEF42EDD9Q37876377-E5E325D2-2910-4BDC-B684-C5CCD1F79D3CQ38017149-ACDB5513-863F-47D1-9C6A-6FA2256E093BQ38029908-DC242036-48CA-4419-8842-951D39B513C6Q38042004-2D5FDC8E-85BF-49D4-A3FB-5EBF4FFF5F87Q38096461-2253B84C-52E1-4310-A256-35A34FECB7E5Q38178752-BB7E0B09-32A6-4CC6-91B7-4853760D9C0AQ38183324-7BFAF597-1A52-4BA9-BC02-EBADCDE6707EQ38244819-25B43D2D-D3BD-460D-9F8D-ABF175493D06Q38853092-1403E6FF-BFFE-4EA8-9C5D-79ED468EA57CQ38948869-4F8D495A-F53A-4A04-BDBA-40F3C40D0AD1Q39096101-CDB1E71F-C0D6-4F53-A8B3-C335B0A8529EQ39117386-8666D9BA-E4BF-46FE-8ECB-46A1E4C86F59Q42119747-1343D62E-A1C5-468A-8E3E-57ED7064D896Q42642010-CC101DE3-868D-41DC-B7F5-B6E43884ABB6Q43199684-7729C2ED-9B70-4BE4-BE82-1DFECDC5238CQ46697457-D681D4A8-8FDE-4DBD-A2D4-219E11CCF648Q47839439-B27A5E65-90EE-4B4A-B622-0826D554B627Q48322881-D58F9FF4-126C-455A-8F72-72D1B98A461FQ48476019-6FD53493-B9D8-4DAB-B877-8D19FD04CD52Q48632301-4B6430D7-0CD1-4E52-AAAE-736C0102A375Q49913933-92D8C82B-B25F-41F6-ACBD-57C59A9AAD15Q54980443-C06BA245-F7F5-4551-B010-7C329F4C6C98Q57655223-AF77FB69-3476-49B8-8153-D05AF6D9AD26Q58739379-36CF9DA3-2EC4-4F1F-AF7C-A6B8961B00FEQ58794431-6BC8C207-6533-4352-8BC1-F42685552287
P2860
High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
High prevalence of long-term c ...... eatment for craniopharyngioma.
@ast
High prevalence of long-term c ...... eatment for craniopharyngioma.
@en
type
label
High prevalence of long-term c ...... eatment for craniopharyngioma.
@ast
High prevalence of long-term c ...... eatment for craniopharyngioma.
@en
prefLabel
High prevalence of long-term c ...... eatment for craniopharyngioma.
@ast
High prevalence of long-term c ...... eatment for craniopharyngioma.
@en
P2093
P2860
P50
P1476
High prevalence of long-term c ...... reatment for craniopharyngioma
@en
P2093
Eleonora P M Corssmit
Eva M Schmid
Ferdinand Roelfsema
Jan W A Smit
Johannes A Romijn
Nienke R Biermasz
Pieter J Schutte
Sjoerd W van Thiel
P2860
P304
P356
10.1111/J.1365-2265.2004.02196.X
P577
2005-02-01T00:00:00Z